Logos Global Management LP Harpoon Therapeutics, Inc. Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.54 - $8.08 $6.83 Million - $15.6 Million	-1,930,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.69 - $7.83 $11 Million - $15.1 Million	1,930,000 New	1,930,000 $14.6 Million
Q3 2021 Nov 15, 2021	SELL	$7.88 - $14.0 $6.3 Million - $11.2 Million	-800,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.81 - $23.25 $6.91 Million - $11.6 Million	500,000 Added 166.67%	800,000 $11.1 Million
Q1 2021 May 17, 2021	BUY	$17.65 - $24.16 $5.3 Million - $7.25 Million	300,000 New	300,000 $6.28 Million

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.